Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonaprument in Dry Age-Related Macular Degeneration With Geographic Atrophy
NCT07807969Phase 3Not yet recruiting
- Sponsor
- Annexon Biosciences
- Start
- Sep 2026
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
A Phase 3 trial of vonaprument in geographic atrophy (GA), sponsored by Annexon Biosciences. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
vonaprument
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT07807969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07807969.